Copyright Reports & Markets. All rights reserved.

Global Transdermal Patch for Pain Relief Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application

Request for Sample of this report
Buy now

Table of Contents

    1 Transdermal Patch for Pain Relief Market Overview

    • 1.1 Transdermal Patch for Pain Relief Product Overview
    • 1.2 Transdermal Patch for Pain Relief Market Segment by Type
      • 1.2.1 Lidocaine Patch
      • 1.2.2 Diclofenac Patch
      • 1.2.3 Indomethacin Patch
      • 1.2.4 Fentanyl Patch
      • 1.2.5 Peppermint Patch
      • 1.2.6 Methyl Salicylate Patch
      • 1.2.7 Capsaicin Patch
      • 1.2.8 Other
    • 1.3 Global Transdermal Patch for Pain Relief Market Size by Type
      • 1.3.1 Global Transdermal Patch for Pain Relief Market Size Overview by Type (2016-2027)
      • 1.3.2 Global Transdermal Patch for Pain Relief Historic Market Size Review by Type (2016-2021)
        • 1.3.2.1 Global Transdermal Patch for Pain Relief Sales Breakdown in Volume by Type (2016-2021)
        • 1.3.2.2 Global Transdermal Patch for Pain Relief Sales Breakdown in Value by Type (2016-2021)
        • 1.3.2.3 Global Transdermal Patch for Pain Relief Average Selling Price (ASP) by Type (2016-2021)
      • 1.3.3 Global Transdermal Patch for Pain Relief Forecasted Market Size by Type (2022-2027)
        • 1.3.3.1 Global Transdermal Patch for Pain Relief Sales Breakdown in Volume by Type (2022-2027)
        • 1.3.3.2 Global Transdermal Patch for Pain Relief Sales Breakdown in Value by Type (2022-2027)
        • 1.3.3.3 Global Transdermal Patch for Pain Relief Average Selling Price (ASP) by Type (2022-2027)
    • 1.4 Key Regions Market Size Segment by Type
      • 1.4.1 North America Transdermal Patch for Pain Relief Sales Breakdown by Type (2016-2021)
      • 1.4.2 Europe Transdermal Patch for Pain Relief Sales Breakdown by Type (2016-2021)
      • 1.4.3 Asia-Pacific Transdermal Patch for Pain Relief Sales Breakdown by Type (2016-2021)
      • 1.4.4 Latin America Transdermal Patch for Pain Relief Sales Breakdown by Type (2016-2021)
      • 1.4.5 Middle East and Africa Transdermal Patch for Pain Relief Sales Breakdown by Type (2016-2021)

    2 Global Transdermal Patch for Pain Relief Market Competition by Company

    • 2.1 Global Top Players by Transdermal Patch for Pain Relief Sales (2016-2021)
    • 2.2 Global Top Players by Transdermal Patch for Pain Relief Revenue (2016-2021)
    • 2.3 Global Top Players Transdermal Patch for Pain Relief Price (2016-2021)
    • 2.4 Global Top Manufacturers Transdermal Patch for Pain Relief Manufacturing Base Distribution, Sales Area, Product Type
    • 2.5 Transdermal Patch for Pain Relief Market Competitive Situation and Trends
      • 2.5.1 Transdermal Patch for Pain Relief Market Concentration Rate (2016-2021)
      • 2.5.2 Global 5 and 10 Largest Manufacturers by Transdermal Patch for Pain Relief Sales and Revenue in 2020
    • 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Transdermal Patch for Pain Relief as of 2020)
    • 2.7 Date of Key Manufacturers Enter into Transdermal Patch for Pain Relief Market
    • 2.8 Key Manufacturers Transdermal Patch for Pain Relief Product Offered
    • 2.9 Mergers & Acquisitions, Expansion

    3 Transdermal Patch for Pain Relief Status and Outlook by Region

    • 3.1 Global Transdermal Patch for Pain Relief Market Size and CAGR by Region: 2016 VS 2021 VS 2026
    • 3.2 Global Transdermal Patch for Pain Relief Historic Market Size by Region
      • 3.2.1 Global Transdermal Patch for Pain Relief Sales in Volume by Region (2016-2021)
      • 3.2.2 Global Transdermal Patch for Pain Relief Sales in Value by Region (2016-2021)
      • 3.2.3 Global Transdermal Patch for Pain Relief Sales (Volume & Value) Price and Gross Margin (2016-2021)
    • 3.3 Global Transdermal Patch for Pain Relief Forecasted Market Size by Region
      • 3.3.1 Global Transdermal Patch for Pain Relief Sales in Volume by Region (2022-2027)
      • 3.3.2 Global Transdermal Patch for Pain Relief Sales in Value by Region (2022-2027)
      • 3.3.3 Global Transdermal Patch for Pain Relief Sales (Volume & Value), Price and Gross Margin (2022-2027)

    4 Global Transdermal Patch for Pain Relief by Application

    • 4.1 Transdermal Patch for Pain Relief Market Segment by Application
      • 4.1.1 OTC
      • 4.1.2 Rx
    • 4.2 Global Transdermal Patch for Pain Relief Market Size by Application
      • 4.2.1 Global Transdermal Patch for Pain Relief Market Size Overview by Application (2016-2027)
      • 4.2.2 Global Transdermal Patch for Pain Relief Historic Market Size Review by Application (2016-2021)
        • 4.2.2.1 Global Transdermal Patch for Pain Relief Sales Breakdown in Volume, by Application (2016-2021)
        • 4.2.2.2 Global Transdermal Patch for Pain Relief Sales Breakdown in Value, by Application (2016-2021)
        • 4.2.2.3 Global Transdermal Patch for Pain Relief Average Selling Price (ASP) by Application (2016-2021)
      • 4.2.3 Global Transdermal Patch for Pain Relief Forecasted Market Size by Application (2022-2027)
        • 4.2.3.1 Global Transdermal Patch for Pain Relief Sales Breakdown in Volume, by Application (2022-2027)
        • 4.2.3.2 Global Transdermal Patch for Pain Relief Sales Breakdown in Value, by Application (2022-2027)
        • 4.2.3.3 Global Transdermal Patch for Pain Relief Average Selling Price (ASP) by Application (2022-2027)
    • 4.3 Key Regions Market Size Segment by Application
      • 4.3.1 North America Transdermal Patch for Pain Relief Sales Breakdown by Application (2016-2021)
      • 4.3.2 Europe Transdermal Patch for Pain Relief Sales Breakdown by Application (2016-2021)
      • 4.3.3 Asia-Pacific Transdermal Patch for Pain Relief Sales Breakdown by Application (2016-2021)
      • 4.3.4 Latin America Transdermal Patch for Pain Relief Sales Breakdown by Application (2016-2021)
      • 4.3.5 Middle East and Africa Transdermal Patch for Pain Relief Sales Breakdown by Application (2016-2021)

    5 North America Transdermal Patch for Pain Relief by Country

    • 5.1 North America Transdermal Patch for Pain Relief Historic Market Size by Country
      • 5.1.1 North America Transdermal Patch for Pain Relief Sales in Volume by Country (2016-2021)
      • 5.1.2 North America Transdermal Patch for Pain Relief Sales in Value by Country (2016-2021)
    • 5.2 North America Transdermal Patch for Pain Relief Forecasted Market Size by Country
      • 5.2.1 North America Transdermal Patch for Pain Relief Sales in Volume by Country (2022-2027)
      • 5.2.2 North America Transdermal Patch for Pain Relief Sales in Value by Country (2022-2027)

    6 Europe Transdermal Patch for Pain Relief by Country

    • 6.1 Europe Transdermal Patch for Pain Relief Historic Market Size by Country
      • 6.1.1 Europe Transdermal Patch for Pain Relief Sales in Volume by Country (2016-2021)
      • 6.1.2 Europe Transdermal Patch for Pain Relief Sales in Value by Country (2016-2021)
    • 6.2 Europe Transdermal Patch for Pain Relief Forecasted Market Size by Country
      • 6.2.1 Europe Transdermal Patch for Pain Relief Sales in Volume by Country (2022-2027)
      • 6.2.2 Europe Transdermal Patch for Pain Relief Sales in Value by Country (2022-2027)

    7 Asia-Pacific Transdermal Patch for Pain Relief by Region

    • 7.1 Asia-Pacific Transdermal Patch for Pain Relief Historic Market Size by Region
      • 7.1.1 Asia-Pacific Transdermal Patch for Pain Relief Sales in Volume by Region (2016-2021)
      • 7.1.2 Asia-Pacific Transdermal Patch for Pain Relief Sales in Value by Region (2016-2021)
    • 7.2 Asia-Pacific Transdermal Patch for Pain Relief Forecasted Market Size by Region
      • 7.2.1 Asia-Pacific Transdermal Patch for Pain Relief Sales in Volume by Region (2022-2027)
      • 7.2.2 Asia-Pacific Transdermal Patch for Pain Relief Sales in Value by Region (2022-2027)

    8 Latin America Transdermal Patch for Pain Relief by Country

    • 8.1 Latin America Transdermal Patch for Pain Relief Historic Market Size by Country
      • 8.1.1 Latin America Transdermal Patch for Pain Relief Sales in Volume by Country (2016-2021)
      • 8.1.2 Latin America Transdermal Patch for Pain Relief Sales in Value by Country (2016-2021)
    • 8.2 Latin America Transdermal Patch for Pain Relief Forecasted Market Size by Country
      • 8.2.1 Latin America Transdermal Patch for Pain Relief Sales in Volume by Country (2022-2027)
      • 8.2.2 Latin America Transdermal Patch for Pain Relief Sales in Value by Country (2022-2027)

    9 Middle East and Africa Transdermal Patch for Pain Relief by Country

    • 9.1 Middle East and Africa Transdermal Patch for Pain Relief Historic Market Size by Country
      • 9.1.1 Middle East and Africa Transdermal Patch for Pain Relief Sales in Volume by Country (2016-2021)
      • 9.1.2 Middle East and Africa Transdermal Patch for Pain Relief Sales in Value by Country (2016-2021)
    • 9.2 Middle East and Africa Transdermal Patch for Pain Relief Forecasted Market Size by Country
      • 9.2.1 Middle East and Africa Transdermal Patch for Pain Relief Sales in Volume by Country (2022-2027)
      • 9.2.2 Middle East and Africa Transdermal Patch for Pain Relief Sales in Value by Country (2022-2027)

    10 Company Profiles and Key Figures in Transdermal Patch for Pain Relief Business

    • 10.1 Hisamitsu
      • 10.1.1 Hisamitsu Corporation Information
      • 10.1.2 Hisamitsu Introduction and Business Overview
      • 10.1.3 Hisamitsu Transdermal Patch for Pain Relief Sales, Revenue and Gross Margin (2016-2021)
      • 10.1.4 Hisamitsu Transdermal Patch for Pain Relief Products Offered
      • 10.1.5 Hisamitsu Recent Development
    • 10.2 Mylan
      • 10.2.1 Mylan Corporation Information
      • 10.2.2 Mylan Introduction and Business Overview
      • 10.2.3 Mylan Transdermal Patch for Pain Relief Sales, Revenue and Gross Margin (2016-2021)
      • 10.2.4 Mylan Transdermal Patch for Pain Relief Products Offered
      • 10.2.5 Mylan Recent Development
    • 10.3 Johnson & Johnson
      • 10.3.1 Johnson & Johnson Corporation Information
      • 10.3.2 Johnson & Johnson Introduction and Business Overview
      • 10.3.3 Johnson & Johnson Transdermal Patch for Pain Relief Sales, Revenue and Gross Margin (2016-2021)
      • 10.3.4 Johnson & Johnson Transdermal Patch for Pain Relief Products Offered
      • 10.3.5 Johnson & Johnson Recent Development
    • 10.4 Teva
      • 10.4.1 Teva Corporation Information
      • 10.4.2 Teva Introduction and Business Overview
      • 10.4.3 Teva Transdermal Patch for Pain Relief Sales, Revenue and Gross Margin (2016-2021)
      • 10.4.4 Teva Transdermal Patch for Pain Relief Products Offered
      • 10.4.5 Teva Recent Development
    • 10.5 Lingrui
      • 10.5.1 Lingrui Corporation Information
      • 10.5.2 Lingrui Introduction and Business Overview
      • 10.5.3 Lingrui Transdermal Patch for Pain Relief Sales, Revenue and Gross Margin (2016-2021)
      • 10.5.4 Lingrui Transdermal Patch for Pain Relief Products Offered
      • 10.5.5 Lingrui Recent Development
    • 10.6 Sanofi
      • 10.6.1 Sanofi Corporation Information
      • 10.6.2 Sanofi Introduction and Business Overview
      • 10.6.3 Sanofi Transdermal Patch for Pain Relief Sales, Revenue and Gross Margin (2016-2021)
      • 10.6.4 Sanofi Transdermal Patch for Pain Relief Products Offered
      • 10.6.5 Sanofi Recent Development
    • 10.7 Qizheng
      • 10.7.1 Qizheng Corporation Information
      • 10.7.2 Qizheng Introduction and Business Overview
      • 10.7.3 Qizheng Transdermal Patch for Pain Relief Sales, Revenue and Gross Margin (2016-2021)
      • 10.7.4 Qizheng Transdermal Patch for Pain Relief Products Offered
      • 10.7.5 Qizheng Recent Development
    • 10.8 Endo
      • 10.8.1 Endo Corporation Information
      • 10.8.2 Endo Introduction and Business Overview
      • 10.8.3 Endo Transdermal Patch for Pain Relief Sales, Revenue and Gross Margin (2016-2021)
      • 10.8.4 Endo Transdermal Patch for Pain Relief Products Offered
      • 10.8.5 Endo Recent Development
    • 10.9 Huarun 999
      • 10.9.1 Huarun 999 Corporation Information
      • 10.9.2 Huarun 999 Introduction and Business Overview
      • 10.9.3 Huarun 999 Transdermal Patch for Pain Relief Sales, Revenue and Gross Margin (2016-2021)
      • 10.9.4 Huarun 999 Transdermal Patch for Pain Relief Products Offered
      • 10.9.5 Huarun 999 Recent Development
    • 10.10 GSK
      • 10.10.1 GSK Corporation Information
      • 10.10.2 GSK Introduction and Business Overview
      • 10.10.3 GSK Transdermal Patch for Pain Relief Sales, Revenue and Gross Margin (2016-2021)
      • 10.10.4 GSK Transdermal Patch for Pain Relief Products Offered
      • 10.10.5 GSK Recent Development
    • 10.11 Haw Par
      • 10.11.1 Haw Par Corporation Information
      • 10.11.2 Haw Par Introduction and Business Overview
      • 10.11.3 Haw Par Transdermal Patch for Pain Relief Sales, Revenue and Gross Margin (2016-2021)
      • 10.11.4 Haw Par Transdermal Patch for Pain Relief Products Offered
      • 10.11.5 Haw Par Recent Development
    • 10.12 Nichiban
      • 10.12.1 Nichiban Corporation Information
      • 10.12.2 Nichiban Introduction and Business Overview
      • 10.12.3 Nichiban Transdermal Patch for Pain Relief Sales, Revenue and Gross Margin (2016-2021)
      • 10.12.4 Nichiban Transdermal Patch for Pain Relief Products Offered
      • 10.12.5 Nichiban Recent Development
    • 10.13 Laboratoires Genevrier
      • 10.13.1 Laboratoires Genevrier Corporation Information
      • 10.13.2 Laboratoires Genevrier Introduction and Business Overview
      • 10.13.3 Laboratoires Genevrier Transdermal Patch for Pain Relief Sales, Revenue and Gross Margin (2016-2021)
      • 10.13.4 Laboratoires Genevrier Transdermal Patch for Pain Relief Products Offered
      • 10.13.5 Laboratoires Genevrier Recent Development
    • 10.14 BLUE-EMU
      • 10.14.1 BLUE-EMU Corporation Information
      • 10.14.2 BLUE-EMU Introduction and Business Overview
      • 10.14.3 BLUE-EMU Transdermal Patch for Pain Relief Sales, Revenue and Gross Margin (2016-2021)
      • 10.14.4 BLUE-EMU Transdermal Patch for Pain Relief Products Offered
      • 10.14.5 BLUE-EMU Recent Development
    • 10.15 IBSA Group
      • 10.15.1 IBSA Group Corporation Information
      • 10.15.2 IBSA Group Introduction and Business Overview
      • 10.15.3 IBSA Group Transdermal Patch for Pain Relief Sales, Revenue and Gross Margin (2016-2021)
      • 10.15.4 IBSA Group Transdermal Patch for Pain Relief Products Offered
      • 10.15.5 IBSA Group Recent Development
    • 10.16 Pfizer
      • 10.16.1 Pfizer Corporation Information
      • 10.16.2 Pfizer Introduction and Business Overview
      • 10.16.3 Pfizer Transdermal Patch for Pain Relief Sales, Revenue and Gross Margin (2016-2021)
      • 10.16.4 Pfizer Transdermal Patch for Pain Relief Products Offered
      • 10.16.5 Pfizer Recent Development
    • 10.17 Performance Health
      • 10.17.1 Performance Health Corporation Information
      • 10.17.2 Performance Health Introduction and Business Overview
      • 10.17.3 Performance Health Transdermal Patch for Pain Relief Sales, Revenue and Gross Margin (2016-2021)
      • 10.17.4 Performance Health Transdermal Patch for Pain Relief Products Offered
      • 10.17.5 Performance Health Recent Development

    11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis

    • 11.1 Transdermal Patch for Pain Relief Key Raw Materials
      • 11.1.1 Key Raw Materials
      • 11.1.2 Key Raw Materials Price
      • 11.1.3 Raw Materials Key Suppliers
    • 11.2 Manufacturing Cost Structure
      • 11.2.1 Raw Materials
      • 11.2.2 Labor Cost
      • 11.2.3 Manufacturing Expenses
    • 11.3 Transdermal Patch for Pain Relief Industrial Chain Analysis
    • 11.4 Transdermal Patch for Pain Relief Market Dynamics
      • 11.4.1 Industry Trends
      • 11.4.2 Market Drivers
      • 11.4.3 Market Challenges
      • 11.4.4 Market Restraints

    12 Market Strategy Analysis, Distributors

    • 12.1 Sales Channel
    • 12.2 Transdermal Patch for Pain Relief Distributors
    • 12.3 Transdermal Patch for Pain Relief Downstream Customers

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Pain Relief patch is a kind of adhesive patch that sticks to the skin and can deliver a specific dose of medicine to the body through the skin. Usually, this promotes the healing of injured parts of the body.
      Market Insights
      QY Research has lately published a report titled “Global Transdermal Patch for Pain Relief Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application”, with the help of industry-leading research methods, along with observing subtle details and understanding the overall dynamics.
      The insights included in this report have been prepared in view of varied aspects that affect the growth. The report elucidates key drivers, trends, prospects, restraining factors, and challenges that players may across in the coming years. With the assistance of this research, players can recognize and capitalize on profitable opportunities. They can further utilize it to make the required advancements in their operations to acquire a competitive advantage over other participants.
      The global Transdermal Patch for Pain Relief market size is projected to reach US$ million by 2027, from US$ million in 2020, at a CAGR of % during 2021-2027.
      Segment Scope
      An intensive study of key type and application segments has been done in this segmentation section. The authors of the report have provided reliable figures including sales and revenue forecast data by type and application for the period 2016-2027. They have also studied how the segments are gaining or losing growth in various geographies and their respective countries. Thanks to this study, readers can thoroughly grasp the growth pattern and potential of different segments.
      Segment by Type
      Lidocaine Patch
      Diclofenac Patch
      Indomethacin Patch
      Fentanyl Patch
      Peppermint Patch
      Methyl Salicylate Patch
      Capsaicin Patch
      Other
      Segment by Application
      OTC
      Rx

      Regional Scope
      This segment of the report offers a thorough regional study of the global Transdermal Patch for Pain Relief market. Drivers and restraints for each region are broadly examined in the report. Readers will get familiar with the driving forces and challenges that are specific to the regions. The specialists have identified growth opportunities in key geographical regions and their respective countries to aid players to reinforce their presence. All the regions and their countries in the report are assessed based on the growth rate, revenue, and sales volume according to the consumption for the period 2016-2027. This geographical analysis will help readers to gain in-depth knowledge of the regional growth. The key geographical regions surveyed in this research report involve North America, Europe, Asia Pacific, Central and South America, and Middle East and Africa. The report has specifically covered major countries including United States, Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.

      Key Players
      This section has provided an exhaustive analysis of the strategies that the companies are focusing on to stay ahead of other players. The strategies mainly involve research and development, new product developments, and mergers and acquisitions. The researchers have also provided revenue shares of the key companies, company overview, and the latest company developments so as to help players to sustain the cutthroat competition. In this section, the report offers global revenue and sales data of manufacturers for the period 2016-2021. Following is the list of key manufacturers observed in this research study:
      Hisamitsu
      Mylan
      Johnson & Johnson
      Teva
      Lingrui
      Sanofi
      Qizheng
      Endo
      Huarun 999
      GSK
      Haw Par
      Nichiban
      Laboratoires Genevrier
      BLUE-EMU
      IBSA Group
      Pfizer
      Performance Health

      Frequently Asked Questions
      Which application segment captured the leading share in the Transdermal Patch for Pain Relief market?
      How fragmented is the Transdermal Patch for Pain Relief market?
      Which are the key growth drivers in the Transdermal Patch for Pain Relief market?
      Which are the top strategies undertaken by the Transdermal Patch for Pain Relief market players?
      Which technological trends are likely to affect the Transdermal Patch for Pain Relief market?
      What is the expected Transdermal Patch for Pain Relief market size by 2027?
      Which companies are dominating the Transdermal Patch for Pain Relief market?
      Which region is projected to witness the fastest growth in the future?
      What factors are restraining the Transdermal Patch for Pain Relief market growth?
      Which are the emerging companies in the Transdermal Patch for Pain Relief market?
      Buy now